Intravenous infiltration occurs when IV fluid or medication inadvertently enters the surrounding tissue rather than remaining within the vascular space. This deviation from the intended pathway can transform a routine intervention into a clinically significant complication, demanding prompt recognition and tailored management. The severity of the event ranges from a minor nuisance with localized swelling to a critical incident involving tissue necrosis or compartment syndrome, depending on the solute concentration and volume involved.
Mechanisms and Primary Causes
The failure of the vascular pathway typically stems from three primary mechanisms: displacement of the catheter, failure of the vein integrity, and issues related to infusion dynamics. Catheter migration occurs when the device moves out of the vein, often due to inadequate stabilization or patient movement, particularly in pediatric or agitated individuals. Vein rupture or perforation is another direct cause, where the needle or catheter breaches the posterior wall of the vessel. Finally, factors such as excessive pressure from the infusion pump or the use of highly osmotic solutions can force fluid through the endothelial lining of the vein into the interstitial space.
Identifying Risk Amplifiers
Certain clinical scenarios and patient characteristics inherently elevate the risk of this incident. Patients with fragile veins, such as the elderly or those undergoing chemotherapy, are more susceptible to vessel collapse. Procedures involving small or rolling veins in the dorsum of the hand require meticulous stabilization. The viscosity and osmolarity of the administered fluid are critical chemical determinants; hypertonic saline or potassium chloride pose a significantly greater threat to tissue viability if extravasation occurs compared to isotonic maintenance fluids.
Clinical Recognition and Assessment
Early detection relies on vigilant monitoring beyond the insertion site for subtle changes in the clinical environment. Healthcare providers should observe for swelling at the site, pallor or coolness of the extremity, and complaints of tightness or burning. Pain that is disproportionate to the expected stimulus during the infusion is a key red flag. If infiltration is suspected, the immediate action is to cease the infusion while maintaining the needle in place to facilitate drainage of the infiltrated fluid, followed by assessment of capillary refill and neurovascular status.
Differentiating Complications
Clinicians must distinguish infiltration from other IV-related complications such as phlebitis or infection. While infiltration presents with localized swelling and coolness due to fluid in the tissue, phlebitis involves erythema and warmth along the vein tract indicative of inflammation. Infection may present with systemic signs like fever or localized purulent drainage. Accurate differentiation is essential to avoid inappropriate interventions, such as applying heat when cold therapy is required for vesicant agents.
Therapeutic Management Strategies
Management is dictated by the nature of the infiltrated substance, categorizing agents as either non-irritating or vesicant. For standard fluids like normal saline, simple aspiration of the residual fluid and elevation of the limb often suffice to resolve the swelling. Conversely, vesicant drugs, including chemotherapy or vasopressors, require aggressive mitigation strategies. This may involve the administration of specific antidotes, such as hyaluronidase or dimethyl sulfoxide, to facilitate dispersion and absorption of the toxic substance.
Meticulous documentation serves both clinical and medico-legal purposes, capturing the timeline of the event and the interventions performed. Accurate records should detail the type of fluid infiltrated, the volume, the time of discovery, the actions taken, and the patient’s response to treatment. Adherence to institutional reporting protocols is vital for incident analysis and the implementation of preventative measures in future practice, ensuring continuous quality improvement in vascular access safety.
